Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Back in the dim and distant past (i.e., the 1960s and 1970s), relatively high levels of tea consumption were common in most of the United Kingdom, and coffee was an uncommon substitute. This is certainly not so true today. However, … READ MORE …
Filed under: Diagnosis, Risk | Tagged: accuracy, media, risk, Scotland, tea | 3 Comments »
In a hype-laden media release from the 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine ongoing in Rhodes, Greece, comes another of those “breakthrough” claims with no actual data. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: hype, media, natural products | 2 Comments »
An unexpected publication in the urology literature is an article analyzing the ways in which selected major media reported on the results of the Prostate Lung Colorectal Ovarian Cancer (PLCO) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) trials after their publication in the New England Journal of Medicine in early 2009. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: ERSPC, media, PLCO, screening | 2 Comments »
There has been a prostate cancer furore in Las Vegas, where a locally respected urologist has had his medical license suspended after being accused of re-using single-use needle guides in the conduct of prostate biopsies (see this article from the Las Vegas Review-Journal). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: crisis management, Las Vegas, media | Leave a Comment »
There has been a flurry of media stories as the “drop dead date” for a decision about approval of sipuleucel-T (Provenge) gets closer and closer. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: media, Provenge, sipuleucel-T | 4 Comments »
“Found, the super molecule to kill prostate cancer cells,” trumpeted the MailOnline. And worse still, “A miracle molecule has been discovered that offers the hope of saving men with currently incurable prostate cancer,” screamed the Press Association. … READ MORE …
Filed under: Drugs in development | Tagged: F77, hype, MAb, media, monoclonal antibody | 15 Comments »
There’s a new diet and prostate cancer story “doing the rounds” in the media. It started out stating that dietary changes can induce “substantial” effects on PSA doubling times among men who have received first-line treatment for prostate cancer. The problem with the story is that is based on a small pilot study published last December, and it fails to point out a number of very important caveats. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: diet, journalist, media, misrepresentation, progression, risk, vegetarian | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site